Tiago Girao
Chief Financial Officer, Plus Therapeutics.
Companies
- Immunovant, Inc.Chief financial officer Apr 28, 2025 to now1
- Landos Biopharma, Inc.Board member Apr 12, 2021 to May 23, 20242
- Plus TherapeuticsChief financial officer Sep 4, 2014 to Jul 27, 20183
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Immunovant, Inc. IMVT240,798 shares4$6.6M at $27.45Jul 23, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 23, 2026Sold 6,798 shares at $38.69 of Immunovant, Inc.4
- Jun 26, 2026Sold 10,000 shares at $38.46 of Immunovant, Inc.5
- Jun 26, 2026Exercised options 10,000 shares at $15.90 of Immunovant, Inc.5
- Apr 23, 2026Sold 25,760 shares at $29.62 of Immunovant, Inc.6
- Apr 7, 2026Granted 64,968 shares of Immunovant, Inc.7
- May 1, 2025Granted 208,388 shares of Immunovant, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARLandos Biopharma, Inc., Board member
- 3
- 4
- 5SEC EDGARForm 4 filed Jun 26, 2026
- 6SEC EDGARForm 4 filed Apr 24, 2026
- 7SEC EDGARForm 4 filed Apr 9, 2026
- 8SEC EDGARForm 4 filed May 5, 2025